Pharmacokinetic Investigation of BSPG Laboratories (BSPG) Cannabidiol in Healthy Participants
Status:
Not yet recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
The goal of the current study is to evaluate the bioavaibiltiy of CBD in normal healthy
Individuals. This is an open cross-over design study in healthy individuals to assess the
safety and pharmacokinetic (PK) effects of cannabidiol.